Top Medical Searches

Roche’s star MS medicine Ocrevus wins EU approval

ZURICH (Reuters) – The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market.

 Read more…

Be Sociable, Share!
January 12th, 2018 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us